Busulfan, Fludarabine, and Alemtuzumab As a Reduced Toxicity Regimen for Children with Malignant and Nonmalignant Diseases Improves Engraftment and Graft-versus-Host Disease without Delaying Immune Reconstitution-Reference-Cited by-同舟云学术

Busulfan, Fludarabine, and Alemtuzumab As a Reduced Toxicity Regimen for Children with Malignant and Nonmalignant Diseases Improves Engraftment and Graft-versus-Host Disease without Delaying Immune Reconstitution

Published:2012-11 Issue:11 Volume:18 Page:1656-1663
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Law Jason,Cowan Morton J.,Dvorak Christopher C.,Musick Lisa,Long-Boyle Janel R.,Baxter-Lowe Lee Ann,Horn Biljana

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference20 articles.

1. Hematopoietic stem cell transplantation for leukemia;Wayne;Pediatr Clin North Am,2010

2. Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends;Smiers;Pediatr Clin North Am,2010

3. Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders;Boelens;Pediatr Clin North Am,2010

4. Hematopoietic stem cell transplantation for bone marrow failure syndromes in children;Myers;Biol Blood Marrow Transplant,2009

5. Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML;Horn;Bone Marrow Transplant,2006

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders;Pediatric Blood & Cancer;2023-04-12

3. Refractory, fatal autoimmune hemolytic anemia due to ineffective thymic‐derived T‐cell reconstitution following allogeneic hematopoietic cell transplantation for hypomorphic RAG1 deficiency;Pediatric Blood & Cancer;2022-12-30

4. Worked to the bone: antibody-based conditioning as the future of transplant biology;Journal of Hematology & Oncology;2022-05-19

5. The Relationship Between Busulfan Exposure and Achievement of Sustained Donor Myeloid Chimerism in Patients with Non-Malignant Disorders;Transplantation and Cellular Therapy;2021-03